Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.39 |
| ▸ | PRKCG | P05129 | 1/20 | 0.39 |
| ▸ | PRKCB | P05771 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.39 |
| ▸ | PRKCH | P24723 | 1/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.39 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.39 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28112288 | 1.00 | LMNA (0.78) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL17260206 | 1.00 | LMNA (0.78) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL38657276 | 1.00 | LMNA (0.78) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL28847035 | 1.00 | LMNA (0.78) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL149832 | 1.00 | LMNA (0.78) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL23463369 | 1.00 | LMNA (0.78) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL17260201 | 1.00 | LMNA (0.78) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL10959498 | 0.97 | LMNA (0.74) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL23363677 | 0.97 | LMNA (0.74) | LMNAACE2BLMOPRM1PTPN1 | |
| SCHEMBL23672996 | 0.97 | LMNA (0.74) | LMNAACE2BLMOPRM1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240326006-A1 | GAS-TO-LIQUID REACTOR AND METHOD OF USING | PLASMERICA LLC (US) | 2024-10-03 | — | — | US | claimed |
| CN-118001879-A | Application of nano copper alloy in filtering harmful substances in cigarette smoke | 广东合一新材料研究院有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-108929597-B | Quantum dot conductive ink and quantum dot film | 苏州星烁纳米科技有限公司 | 2021-10-22 | — | — | CN | claimed |
| US-10737235-B2 | Gas-to-liquid reactor and method of using | PLASMERICA, LLC (US) | 2020-08-11 | — | — | US | claimed |
| CN-109096825-A | quantum dot ink and quantum dot film | 苏州星烁纳米科技有限公司 | 2018-12-28 | — | — | CN | claimed |
| CN-109021702-A | quantum dot ink and quantum dot film | 苏州星烁纳米科技有限公司 | 2018-12-18 | — | — | CN | claimed |
| US-20180243721-A1 | GAS-TO-LIQUID REACTOR AND METHOD OF USING | PLASMERICA, LLC | 2018-08-30 | — | — | US | claimed |
| CN-104854069-B | (6R,10R) -6,10, 14-trimethylpentadecan-2-one prepared from 6, 10-dimethylundec-5-en-2-one or 6, 10-dimethylundec-5, 9-dien-2-one | 帝斯曼知识产权资产管理有限公司 | 2017-06-20 | — | — | CN | claimed |
| WO-2017040704-A1 | GAS-TO-LIQUID REACTOR AND METHOD OF USING | PLASMERICA, LLC (US) | 2017-03-09 | — | — | WO | claimed |
| CN-103058841-B | Preparation method of alpha-damascenone perfume | UNIV HENAN NORMAL | 2015-05-06 | — | — | CN | claimed |
| EP-2406370-A1 | ALGAE BIOMASS FRACTIONATION | SRS Energy (US) | 2012-01-18 | — | — | EP | claimed |
| WO-2010104922-A1 | ALGAE BIOMASS FRACTIONATION | SRS ENERGY (US) | 2010-09-16 | — | — | WO | claimed |
| US-20100233761-A1 | ALGAE BIOMASS FRACTIONATION | Valicor, Inc. | 2010-09-16 | — | — | US | claimed |
| EP-4747303-A2 | DISTILLATION OF PLASTIC WASTE TO FORM WATERPROOFING PRODUCTS | Fairway Cost Consultancy Limited (GB) | 2026-05-27 | — | — | EP | disclosed |
| CN-122030497-A | Fermentation method for cooperatively treating ganoderma lucidum by bacterial enzymes and application of fermentation method in pet food | 杭州半边野兽科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12528999-B2 | Sustainable jet fuel and process | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-01-20 | — | — | US | disclosed |
| EP-0016546-A1 | Extracellular microbial lipoheteropolysaccharides and derivatives, their preparation and compositions containing them, and their uses | Petroleum Fermentations N.V. (AN) | 1980-10-01 | — | — | EP | disclosed |
| US-4179293-A | HYDROQUINONE COMPOUND AS AN ANTIFOGGING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1979-12-18 | — | — | US | disclosed |
| EP-0003211-A1 | Process to control pests with imidazole derivatives | BASF Aktiengesellschaft (DE) | 1979-08-08 | — | — | EP | disclosed |
| EP-0001809-A1 | Synergetic insecticidal and acaricidal mixtures | BASF Aktiengesellschaft (DE) | 1979-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528999-B2 | Sustainable jet fuel and process | CYP2E1, ADH1C, PCCA | LMNA 2064/4885ACE2 2819/4885BLM 1347/4885 |
| US-20180243721-A1 | GAS-TO-LIQUID REACTOR AND METHOD OF USING | VEGFA, FLT1, KDR | LMNA 1295/4885ACE2 1126/4885BLM 362/4885 |
| US-20240326006-A1 | GAS-TO-LIQUID REACTOR AND METHOD OF USING | VEGFA, FLT1, KDR | LMNA 1295/4885ACE2 1126/4885BLM 362/4885 |
| US-10737235-B2 | Gas-to-liquid reactor and method of using | VEGFA, FLT1, KDR | LMNA 1295/4885ACE2 1126/4885BLM 362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.